Carl J. Fichtenbaum
Division of Infectious Diseases
University of Cincinnati College of Medicine
231 Albert Sabin Way
PO Box 670560
USA
Name/email consistency: high
- Inflammatory Markers Associated with Coronary Heart Disease in Persons with HIV Infection. Fichtenbaum, C.J. Curr. Infect. Dis. Rep (2011)
- Treatment with pravastatin and fenofibrate improves atherogenic lipid profiles but not inflammatory markers in ACTG 5087. Fichtenbaum, C.J., Yeh, T.M., Evans, S.R., Aberg, J.A. J. Clin. Lipidol (2010)
- Metabolic abnormalities associated with HIV infection and antiretroviral therapy. Fichtenbaum, C.J. Curr. Infect. Dis. Rep (2009)
- Coronary heart disease risk, dyslipidemia, and management in HIV-infected persons. Fichtenbaum, C.J. HIV. Clin. Trials (2004)
- Refractory mucosal candidiasis in advanced human immunodeficiency virus infection. Fichtenbaum, C.J., Koletar, S., Yiannoutsos, C., Holland, F., Pottage, J., Cohn, S.E., Walawander, A., Frame, P., Feinberg, J., Saag, M., Van der Horst, C., Powderly, W.G. Clin. Infect. Dis. (2000)
- Amphotericin B oral suspension for fluconazole-refractory oral candidiasis in persons with HIV infection. Adult AIDS Clinical Trials Group Study Team 295. Fichtenbaum, C.J., Zackin, R., Rajicic, N., Powderly, W.G., Wheat, L.J., Zingman, B.S. AIDS (2000)
- A pilot study of the management of uncomplicated candidemia with a standardized protocol of amphotericin B. Fichtenbaum, C.J., German, M., Dunagan, W.C., Fraser, V.J., Medoff, G., Diego, J., Powderly, W.G. Clin. Infect. Dis. (1999)